Key result
Higher HDL-C variability linked to ~30% increased risk of COPD in older adults.
Why the study?
Does higher HDL-C variability increase the risk of COPD in middle-aged and older Chinese adults?
Cohort (n=5,610)
Does higher HDL-C variability increase the risk of COPD in middle-aged and older Chinese adults?
Odds Ratio: 1.3 (95% CI 1.07–1.57)
p-value: p=0.01
Higher visit-to-visit HDL-C variability is independently associated with an increased risk of COPD in middle-aged and older Chinese adults, suggesting it may serve as a novel risk marker.
Background Chronic obstructive pulmonary disease (COPD) is a significant public health issue, especially among middle-aged and older populations. Although variability in high-density lipoprotein cholesterol (HDL-C) have been linked to various health outcomes, their relationship with COPD remains insufficiently understood. This study aims to evaluate the association between HDL-C variability and COPD risk in a Chinese cohort using a retrospective design. Methods A total of 5,610 participants from the China Health and Retirement Longitudinal Study (CHARLS) were included, each of whom had undergone at least two consecutive health assessments in the 2011 and 2015. HDL-C variability was assessed using three indicators: (1) variability independent of the mean (VIM), (2) average real variability (ARV), and (3) the standard deviation (SD) of HDL-C levels from baseline to follow-up. COPD status was determined through a questionnaire in 2018. Logistic regression models were applied to examine the association between HDL-C variability and COPD risk, with results expressed as odds ratios (ORs) and 95% confidence intervals (CIs). Results Among CHARLS participants (mean age 58.72 ± 8.52 years; 44.71% male), higher HDL-C variability was associated with increased COPD risk. The highest quartile of ARV showed a significant association compared with the lowest quartile [OR 1.30, 95% CI 1.07–1.57; P = 0.01; P for trend = 0.02], and each one standard deviation increase in ARV corresponded to an OR of 1.11 (95% CI 1.03–1.18, P < 0.01), indicating a dose–response relationship. Results for SD were similar, whereas VIM was significant only as a continuous variable. Conclusion Higher visit-to-visit HDL-C variability independently increased COPD risk in middle-aged and older Chinese adults. HDL-C variability represents a novel risk marker beyond static lipid levels. Stabilizing HDL-C could offer a potential preventive strategy, warranting further mechanistic and interventional studies.
No takes yet. Share an insight, caveat, or question.
Zhan et al. (2025) conducted a cohort in Chronic obstructive pulmonary disease (COPD) (n=5,610). High HDL-C variability vs. Lowest quartile of HDL-C variability was evaluated on COPD risk (OR 1.30, 95% CI 1.07-1.57, p=0.01). Higher visit-to-visit HDL-C variability was associated with an increased risk of COPD in middle-aged and older Chinese adults (highest vs lowest quartile of ARV: OR 1.30; 95% CI 1.07-1.57; P=0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: